![Reinhard Schneider](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Reinhard Schneider
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Luxfold S.A.
![]() Luxfold S.A. BiotechnologyHealth Technology Luxfold S.A. designs and engineers protein structures. It offers protein three-dimensional structure. The company is headquartered in Luxembourg.
2
| Private Company | Biotechnology | 2 |
ITTM SA
![]() ITTM SA Data Processing ServicesTechnology Services ITTM SA provides data integration and knowledge management solutions to bio-medical research areas. Its solutions include data curation, transmart hosting, software development, and data archiving and backup. The company is headquartered in Esch-sur-Alzette, Luxembourg.
2
| Private Company | Data Processing Services | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Reinhard Schneider via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BIO-RAD LABORATORIES, INC. | Medical Specialties | Corporate Officer/Principal | |
Advent Venture Partners LLP
![]() Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
St. John's University | College/University | Masters Business Admin | |
GENFIT | Pharmaceuticals: Major | Director/Board Member | |
NEOVACS | Pharmaceuticals: Major | President | |
The International School of Management | College/University | Graduate Degree | |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Founder | |
Sanofi Diagnostics Pasteur, Inc. | Chief Tech/Sci/R&D Officer | ||
Université de Rouen Normandie | College/University | Doctorate Degree | |
Integrated Biobank of Luxembourg
![]() Integrated Biobank of Luxembourg Medical/Nursing ServicesHealth Services Integrated Biobank of Luxembourg (IBBL) is a non-profit company that provides biobanking-related services. The company is based in Luxembourg, Luxembourg. These services include the collection, processing, analysis, and storage of biological samples and associated data. IBBL performs biospecimen research to optimize sample processing and certify biospecimen quality. | Medical/Nursing Services | Chief Executive Officer | |
QUOTIENT LIMITED | Electronic Equipment/Instruments | Director/Board Member | |
Fondation Arc en Ciel | Miscellaneous Commercial Services | Director/Board Member | |
Luxembourg Institute of Health
![]() Luxembourg Institute of Health Miscellaneous Commercial ServicesCommercial Services Luxembourg Institute of Health (LIH) is an interdisciplinary research organization that focuses on identifying environmental, lifestyle, and behavioral factors affecting health. The private company is based in Strassen, Luxembourg. LIH uses its expertise in digital epidemiology, human biomonitoring, sport medicine, nutrition, and molecular biology to support the implementation and evaluation of new e-health technologies in the context of disease prevention and improving population health. Cancer is a priority disease for LIH, and Precision Oncology is at the heart of their efforts. The CEO of the Luxembourger company is Ulf Nehrbass. | Miscellaneous Commercial Services | Chief Executive Officer | |
Orphalan SA
![]() Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chairman | |
AdBio Partners SAS
![]() AdBio Partners SAS Investment ManagersFinance AdBio Partners SAS (AdBio Partners) is a venture capital firm founded in 2015. The firm is headquartered in Paris, France. | Investment Managers | Founder | |
Tridek-One Therapeutics SAS
![]() Tridek-One Therapeutics SAS Miscellaneous Commercial ServicesCommercial Services Tridek-One Therapeutics SAS is a French private biotechnology company founded in 2018. The company is based in Paris, France. Tridek-One's scientific founders at INSERM conducted groundbreaking research on the role of CD31 in the modulation of the immune response, which forms the basis of the company's work. The company was founded in 2019 by Giuseppina Caligiuri, Antonino Nicoletti, and the CEO is Laurence de Schoulepnikoff. | Miscellaneous Commercial Services | Director/Board Member | |
Urania Therapeutics SAS
![]() Urania Therapeutics SAS BiotechnologyHealth Technology Urania Therapeutics SAS develops therapeutic solutions for the treatment of genetic diseases caused by pathogenic nonsense mutations. The company was founded by Jean-Paul Renaud, Marat Yusupova, and Gulnara Yusupova in October 2015 and is headquartered in Illkirc, France. | Biotechnology | Chairman | |
Alderaan Biotechnology SAS
![]() Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Augustine Therapeutics NV
![]() Augustine Therapeutics NV Medical/Nursing ServicesHealth Services Augustine Therapeutics NV is a Belgian company that focuses on developing innovative therapies for neuromuscular and neurodegenerative diseases. The company is based in Leuven, Belgium. The company's main focus is on HDAC6, a class II histone deacetylase, which is a well-known molecular target in various diseases, particularly neurodegenerative disorders and neuropathies. The company was founded in 2019, and Sylvain Celanire has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member | |
DiogenX SAS
![]() DiogenX SAS BiotechnologyHealth Technology DiogenX SAS engages in the discovery and development of biologics therapeutics options of Diabetic patients. It operates in Diabetes preclinical stage business segment. The company was founded by Benjamin Charles, Patrick Collombat and Jean Pascal Tranié on December 24, 2019 and is headquartered in Marseille, France. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
Frankrijk | 14 |
Verenigde Staten | 4 |
Luxemburg | 3 |
Verenigd Koninkrijk | 2 |
Zwitserland | 2 |
Sectoraal
Health Technology | 8 |
Consumer Services | 5 |
Commercial Services | 5 |
Finance | 3 |
Health Services | 3 |
Operationeel
Director/Board Member | 8 |
Chairman | 4 |
Founder | 4 |
President | 3 |
Corporate Officer/Principal | 3 |
Sterkste connecties
Insiders | |
---|---|
Alain Huriez | 12 |
Catherine Larue | 11 |
Paola Pozzo | 1 |
Andreas Kremer | 1 |
- Beurs
- Insiders
- Reinhard Schneider
- Bedrijfsconnecties